Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation

K. Scott Baker, Stella M. Davies, Navneet S. Majhail, Anna Hassebroek, John P. Klein, Karen K. Ballen, Carolyn L. Bigelow, Haydar A. Frangoul, Cheryl L. Hardy, Christopher Bredeson, Jason Dehn, Debra Friedman, Theresa Hahn, Gregory Hale, Hillard M. Lazarus, C. F. LeMaistre, Fausto Loberiza, Dipnarine Maharaj, Philip McCarthy, Michelle Setterholm & 6 others Stephen Spellman, Michael Trigg, Richard Maziarz, Galen Switzer, Stephanie J. Lee, J. Douglas Rizzo

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

Success of hematopoietic cell transplantation (HCT) can vary by race, but the impact of socioeconomic status (SES) is not known. To evaluate the role of race and SES, we studied 6207 unrelated-donor myeloablative (MA) HCT recipients transplanted between 1995 and 2004 for acute or chronic leukemia or myelodysplastic syndrome (MDS). Patients were reported by transplant center to be White (n = 5253), African American (n = 368), Asian/Pacific-Islander (n = 141), or Hispanic (n = 445). Patient income was estimated from residential zip code at time of HCT. Cox regression analysis adjusting for other significant factors showed that African American (but not Asian or Hispanic) recipients had worse overall survival (OS) (relative-risk [RR] 1.47; 95% confidence interval [CI] 1.29-1.68, P <.001) compared to Whites. Treatment-related mortality (TRM) was higher in African Americans (RR 1.56; 95% CI 1.34-1.83, P <.001) and in Hispanics (RR 1.30; 95% CI 1.11-1.51, P = .001). Across all racial groups, patients with median incomes in the lowest quartile (

Original languageEnglish (US)
Pages (from-to)1543-1554
Number of pages12
JournalBiology of Blood and Marrow Transplantation
Volume15
Issue number12
DOIs
StatePublished - Dec 2009

Fingerprint

Unrelated Donors
Cell Transplantation
Hispanic Americans
Social Class
African Americans
Confidence Intervals
Myelodysplastic Syndromes
Leukemia
Regression Analysis
Transplants
Survival
Mortality
Therapeutics

Keywords

  • Allogeneic hematopoietic cell transplantation
  • Race
  • Socioeconomic status
  • Survival
  • Unrelated donor

ASJC Scopus subject areas

  • Transplantation
  • Hematology

Cite this

Baker, K. S., Davies, S. M., Majhail, N. S., Hassebroek, A., Klein, J. P., Ballen, K. K., ... Rizzo, J. D. (2009). Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 15(12), 1543-1554. https://doi.org/10.1016/j.bbmt.2009.07.023

Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation. / Baker, K. Scott; Davies, Stella M.; Majhail, Navneet S.; Hassebroek, Anna; Klein, John P.; Ballen, Karen K.; Bigelow, Carolyn L.; Frangoul, Haydar A.; Hardy, Cheryl L.; Bredeson, Christopher; Dehn, Jason; Friedman, Debra; Hahn, Theresa; Hale, Gregory; Lazarus, Hillard M.; LeMaistre, C. F.; Loberiza, Fausto; Maharaj, Dipnarine; McCarthy, Philip; Setterholm, Michelle; Spellman, Stephen; Trigg, Michael; Maziarz, Richard; Switzer, Galen; Lee, Stephanie J.; Rizzo, J. Douglas.

In: Biology of Blood and Marrow Transplantation, Vol. 15, No. 12, 12.2009, p. 1543-1554.

Research output: Contribution to journalArticle

Baker, KS, Davies, SM, Majhail, NS, Hassebroek, A, Klein, JP, Ballen, KK, Bigelow, CL, Frangoul, HA, Hardy, CL, Bredeson, C, Dehn, J, Friedman, D, Hahn, T, Hale, G, Lazarus, HM, LeMaistre, CF, Loberiza, F, Maharaj, D, McCarthy, P, Setterholm, M, Spellman, S, Trigg, M, Maziarz, R, Switzer, G, Lee, SJ & Rizzo, JD 2009, 'Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation', Biology of Blood and Marrow Transplantation, vol. 15, no. 12, pp. 1543-1554. https://doi.org/10.1016/j.bbmt.2009.07.023
Baker, K. Scott ; Davies, Stella M. ; Majhail, Navneet S. ; Hassebroek, Anna ; Klein, John P. ; Ballen, Karen K. ; Bigelow, Carolyn L. ; Frangoul, Haydar A. ; Hardy, Cheryl L. ; Bredeson, Christopher ; Dehn, Jason ; Friedman, Debra ; Hahn, Theresa ; Hale, Gregory ; Lazarus, Hillard M. ; LeMaistre, C. F. ; Loberiza, Fausto ; Maharaj, Dipnarine ; McCarthy, Philip ; Setterholm, Michelle ; Spellman, Stephen ; Trigg, Michael ; Maziarz, Richard ; Switzer, Galen ; Lee, Stephanie J. ; Rizzo, J. Douglas. / Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation. In: Biology of Blood and Marrow Transplantation. 2009 ; Vol. 15, No. 12. pp. 1543-1554.
@article{05a2e1a6203e443d98a69f2f00108cd9,
title = "Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation",
abstract = "Success of hematopoietic cell transplantation (HCT) can vary by race, but the impact of socioeconomic status (SES) is not known. To evaluate the role of race and SES, we studied 6207 unrelated-donor myeloablative (MA) HCT recipients transplanted between 1995 and 2004 for acute or chronic leukemia or myelodysplastic syndrome (MDS). Patients were reported by transplant center to be White (n = 5253), African American (n = 368), Asian/Pacific-Islander (n = 141), or Hispanic (n = 445). Patient income was estimated from residential zip code at time of HCT. Cox regression analysis adjusting for other significant factors showed that African American (but not Asian or Hispanic) recipients had worse overall survival (OS) (relative-risk [RR] 1.47; 95{\%} confidence interval [CI] 1.29-1.68, P <.001) compared to Whites. Treatment-related mortality (TRM) was higher in African Americans (RR 1.56; 95{\%} CI 1.34-1.83, P <.001) and in Hispanics (RR 1.30; 95{\%} CI 1.11-1.51, P = .001). Across all racial groups, patients with median incomes in the lowest quartile (",
keywords = "Allogeneic hematopoietic cell transplantation, Race, Socioeconomic status, Survival, Unrelated donor",
author = "Baker, {K. Scott} and Davies, {Stella M.} and Majhail, {Navneet S.} and Anna Hassebroek and Klein, {John P.} and Ballen, {Karen K.} and Bigelow, {Carolyn L.} and Frangoul, {Haydar A.} and Hardy, {Cheryl L.} and Christopher Bredeson and Jason Dehn and Debra Friedman and Theresa Hahn and Gregory Hale and Lazarus, {Hillard M.} and LeMaistre, {C. F.} and Fausto Loberiza and Dipnarine Maharaj and Philip McCarthy and Michelle Setterholm and Stephen Spellman and Michael Trigg and Richard Maziarz and Galen Switzer and Lee, {Stephanie J.} and Rizzo, {J. Douglas}",
year = "2009",
month = "12",
doi = "10.1016/j.bbmt.2009.07.023",
language = "English (US)",
volume = "15",
pages = "1543--1554",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation

AU - Baker, K. Scott

AU - Davies, Stella M.

AU - Majhail, Navneet S.

AU - Hassebroek, Anna

AU - Klein, John P.

AU - Ballen, Karen K.

AU - Bigelow, Carolyn L.

AU - Frangoul, Haydar A.

AU - Hardy, Cheryl L.

AU - Bredeson, Christopher

AU - Dehn, Jason

AU - Friedman, Debra

AU - Hahn, Theresa

AU - Hale, Gregory

AU - Lazarus, Hillard M.

AU - LeMaistre, C. F.

AU - Loberiza, Fausto

AU - Maharaj, Dipnarine

AU - McCarthy, Philip

AU - Setterholm, Michelle

AU - Spellman, Stephen

AU - Trigg, Michael

AU - Maziarz, Richard

AU - Switzer, Galen

AU - Lee, Stephanie J.

AU - Rizzo, J. Douglas

PY - 2009/12

Y1 - 2009/12

N2 - Success of hematopoietic cell transplantation (HCT) can vary by race, but the impact of socioeconomic status (SES) is not known. To evaluate the role of race and SES, we studied 6207 unrelated-donor myeloablative (MA) HCT recipients transplanted between 1995 and 2004 for acute or chronic leukemia or myelodysplastic syndrome (MDS). Patients were reported by transplant center to be White (n = 5253), African American (n = 368), Asian/Pacific-Islander (n = 141), or Hispanic (n = 445). Patient income was estimated from residential zip code at time of HCT. Cox regression analysis adjusting for other significant factors showed that African American (but not Asian or Hispanic) recipients had worse overall survival (OS) (relative-risk [RR] 1.47; 95% confidence interval [CI] 1.29-1.68, P <.001) compared to Whites. Treatment-related mortality (TRM) was higher in African Americans (RR 1.56; 95% CI 1.34-1.83, P <.001) and in Hispanics (RR 1.30; 95% CI 1.11-1.51, P = .001). Across all racial groups, patients with median incomes in the lowest quartile (

AB - Success of hematopoietic cell transplantation (HCT) can vary by race, but the impact of socioeconomic status (SES) is not known. To evaluate the role of race and SES, we studied 6207 unrelated-donor myeloablative (MA) HCT recipients transplanted between 1995 and 2004 for acute or chronic leukemia or myelodysplastic syndrome (MDS). Patients were reported by transplant center to be White (n = 5253), African American (n = 368), Asian/Pacific-Islander (n = 141), or Hispanic (n = 445). Patient income was estimated from residential zip code at time of HCT. Cox regression analysis adjusting for other significant factors showed that African American (but not Asian or Hispanic) recipients had worse overall survival (OS) (relative-risk [RR] 1.47; 95% confidence interval [CI] 1.29-1.68, P <.001) compared to Whites. Treatment-related mortality (TRM) was higher in African Americans (RR 1.56; 95% CI 1.34-1.83, P <.001) and in Hispanics (RR 1.30; 95% CI 1.11-1.51, P = .001). Across all racial groups, patients with median incomes in the lowest quartile (

KW - Allogeneic hematopoietic cell transplantation

KW - Race

KW - Socioeconomic status

KW - Survival

KW - Unrelated donor

UR - http://www.scopus.com/inward/record.url?scp=70350774049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350774049&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2009.07.023

DO - 10.1016/j.bbmt.2009.07.023

M3 - Article

VL - 15

SP - 1543

EP - 1554

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 12

ER -